FDA shifts drug testing paradigm with plan to replace animal studies in monoclonal antibody development June 24, 2025July 9, 2025 Share More from the Blog A Regulatory Turning Point: A Recent Timeline of U.S. Actions to Reduce and Replace Animal Models in Preclinical Research Read More Protecting Human Health with Organ-on-a-Chip Technology Read More Building a Human-Centric Future for Biologics Development with Organ-on-a-Chip Technology Read More Browse All